Cartesian Therapeutics, Inc.
← Back to RNAC Overview

Cartesian Therapeutics, Inc. (RNAC)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.05

Financial Fundamentals

RNAC • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2015-03-31-6.18
2015-06-30-5.34
2015-09-30-5.96
2015-12-31—
2016-03-31-6.02
2016-06-30-1.27
2016-09-30-8.35
2016-12-31-5.56
2017-03-31-4.37
2017-06-30-5.85
2017-09-30-6.86
2017-12-31-2.92
2018-03-31-3.58
2018-06-30-3.94
2018-09-30-5.58
2018-12-31-1.02
2019-03-31-2.01
2019-06-30-1.20
2019-09-30-1.69
2019-12-31-2.09
2020-03-31-2.91
2020-06-30-2.86
2020-09-30-6.71
2020-12-31-5.28
2021-03-31-5.10
2021-06-3025.91
2021-09-30-6.70
2021-12-317.84
2022-03-311.33
2022-06-305.65
2022-09-30-8.20
2022-12-317.31
2023-03-31-2.46
2023-06-30-3.77
2023-09-30-4.57
2023-12-31-0.12
2024-03-31-0.40
2024-06-3010.46
2024-09-30-3.57
2024-12-31-64.89
2025-03-31-4.85
2025-06-304.26
2025-09-30-1.85
2025-12-31-0.51
2026-03-31-1.05

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.